维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Montaner JS"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Expansion ofHAART coverage is associated with sustained decreasesin HIV/AIDS morbidity, mortality and HIV transmission ;the “HIV Treatment as Prevention” experience in a Cana-dian setting 显示文摘	Montaner JS Lima VD Harrigan PR	2014	PLoS One2014，9，87：	1
2	Expanding access toHIV antiretroviral therapy among marginalized populations in thedeveloped world显示文摘	Wood E Montaner JS Bangsberg DR	2003	AIDS2003，17，：	1
3	Association of highly active antiretroviral therapy coverage,population viral load,and yearly new HIV diagnoses in British Columbia,Canada:a population-based study显示文摘	Montaner JS Lima VD Barrios R	2010	Lancet2010，376，9740：	1
4	Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1显示文摘	Montaner JS Cahn P Zala C	2003	J Acquir Immune Defic Syndr2003，33，1：	1
5	A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV trials network protocol 080 显示文摘	Montaner JS Zala C Conway B	1997	J Infect Dis1997，175，：	1
6	The safety of tenofo- vir disoproxil fumarate for the treatment of HIV infection in adults : the first 4 years显示文摘	Nelson MR Katlama C Montaner JS	2007	AIDS2007，21，10：	1
7	Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis 显示文摘	Werb D Mills EJ Montaner JS etal	2010	Lancet Infect Dis2010，10，7：	1
8	Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS mor- bidity,mortality and HIV transmission:the 'HIV Treatment as Pre- vention' experience in a Canadian setting显示文摘	Montaner JS Lima VD Harrigan PR	2014	PLoS One2014，9，87：	1
9	The case for ex- panding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic显示文摘	Montaner JS Hogg R Wood E	2006	Lancet2006，368，9534：	1
10	Suppression of plas ma viral load below 20 copies/mL is required to achieve a lonterm response to therapy显示文摘	Raboud JM Montaner JS Conway B	1998	AIDS1998，12，：	1
11	Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity,mortality and HIV transmission:the'HIV treatment as prevention'experience in a Canadian setting显示文摘	Montaner JS Lima VD Harrigan PR	2014	PLoS One2014，2，87：	1
12	Hepatotoxicity of nucleoside reverse transcriptase inhibitors 显示文摘	Montessori V Harris M Montaner JS	2003	Semin Liver Dis2003，23，2：	1
13	Changing global epidemiology of pulmonary manifestations of HIV/AIDS显示文摘	Hull MW Phillips P Montaner JS	2008	Chest2008，134，6：	1
14	Complementary and alternative medicine use in British Columbia a survey of HIV positive people on antiretroviral therapy显示文摘	Dhalla S Chan K J Montaner JS	2006	Complement Ther Clin Pract2006，12，4：	1
15	Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected in- jection drug users显示文摘	Wood E Montaner JS Yip B	2004	Antivir Ther2004，9，：	1
16	The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years显示文摘	Nelson MR Katlama C Montaner JS	2007	AIDS2007，21，10：	1
17	The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults:the first 4 years显示文摘	Nelson MR Katlama C Montaner JS	2007	AIDS2007，21，10：	1
18	The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years显示文摘	Nelson MR Katlama C Montaner JS	2007	AIDS2007，21，10：	1
19	The safety of tenofo- vir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years 显示文摘	Nelson MR Katlama C Montaner JS	2007	AIDS2007，21，10：	1
20	Antiretroviral treatment in 1998显示文摘	Montaner JS Hogg R Raboud J	1998	Lancet1998，352，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示